Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube.

Andersson M, Kjellgren A.

Harm Reduct J. 2019 Nov 28;16(1):63. doi: 10.1186/s12954-019-0333-3.

2.

Microdosing psychedelics: Motivations, subjective effects and harm reduction.

Lea T, Amada N, Jungaberle H, Schecke H, Klein M.

Int J Drug Policy. 2019 Nov 25;75:102600. doi: 10.1016/j.drugpo.2019.11.008. [Epub ahead of print]

PMID:
31778967
3.

Psychedelic Microdosing: A Subreddit Analysis.

Lea T, Amada N, Jungaberle H.

J Psychoactive Drugs. 2019 Oct 24:1-12. doi: 10.1080/02791072.2019.1683260. [Epub ahead of print]

PMID:
31648596
4.

Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers.

Hutten NRPW, Mason NL, Dolder PC, Kuypers KPC.

Front Psychiatry. 2019 Sep 13;10:672. doi: 10.3389/fpsyt.2019.00672. eCollection 2019.

5.

Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.

Kuypers KP, Ng L, Erritzoe D, Knudsen GM, Nichols CD, Nichols DE, Pani L, Soula A, Nutt D.

J Psychopharmacol. 2019 Sep;33(9):1039-1057. doi: 10.1177/0269881119857204. Epub 2019 Jul 14.

6.

Psychedelic microdosing benefits and challenges: an empirical codebook.

Anderson T, Petranker R, Christopher A, Rosenbaum D, Weissman C, Dinh-Williams LA, Hui K, Hapke E.

Harm Reduct J. 2019 Jul 10;16(1):43. doi: 10.1186/s12954-019-0308-4.

7.

Motives and Side-Effects of Microdosing With Psychedelics Among Users.

Hutten NRPW, Mason NL, Dolder PC, Kuypers KPC.

Int J Neuropsychopharmacol. 2019 Jul 1;22(7):426-434. doi: 10.1093/ijnp/pyz029.

8.

Narrative identity, rationality, and microdosing classic psychedelics.

Webb M, Copes H, Hendricks PS.

Int J Drug Policy. 2019 Aug;70:33-39. doi: 10.1016/j.drugpo.2019.04.013. Epub 2019 May 6.

PMID:
31071597
9.

Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration.

Fadiman J, Korb S.

J Psychoactive Drugs. 2019 Apr-Jun;51(2):118-122. doi: 10.1080/02791072.2019.1593561. Epub 2019 Mar 29.

PMID:
30925850
10.

Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.

Sakloth F, Leggett E, Moerke MJ, Townsend EA, Banks ML, Negus SS.

Exp Clin Psychopharmacol. 2019 Jun;27(3):215-226. doi: 10.1037/pha0000253. Epub 2019 Jan 10.

PMID:
30628811
11.

Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.

Anderson T, Petranker R, Rosenbaum D, Weissman CR, Dinh-Williams LA, Hui K, Hapke E, Farb NAS.

Psychopharmacology (Berl). 2019 Feb;236(2):731-740. doi: 10.1007/s00213-018-5106-2. Epub 2019 Jan 2.

PMID:
30604183
12.

Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats.

Horsley RR, Páleníček T, Kolin J, Valeš K.

Behav Pharmacol. 2018 Sep;29(6):530-536. doi: 10.1097/FBP.0000000000000394.

PMID:
29537989

Supplemental Content

Loading ...
Support Center